Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Integer Holdings Corp (ITGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,407,472
  • Shares Outstanding, K 32,010
  • Annual Sales, $ 1,462 M
  • Annual Income, $ 66,680 K
  • 36-Month Beta 0.84
  • Price/Sales 1.69
  • Price/Cash Flow 11.99
  • Price/Book 2.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.92
  • Number of Estimates 2
  • High Estimate 0.97
  • Low Estimate 0.86
  • Prior Year 0.82
  • Growth Rate Est. (year over year) +12.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.69 +2.89%
on 10/11/18
84.20 -11.18%
on 09/21/18
-6.31 (-7.78%)
since 09/19/18
3-Month
67.85 +10.23%
on 08/15/18
84.20 -11.18%
on 09/21/18
+2.34 (+3.23%)
since 07/19/18
52-Week
42.50 +75.98%
on 02/09/18
84.20 -11.18%
on 09/21/18
+20.79 (+38.50%)
since 10/19/17

Most Recent Stories

More News
Here's Why You Should Hold Integer Holdings in Your Portfolio

Integer Holdings' (ITGR) new strategy to drive sales and profit growth to provide the company with a competitive edge in the MedTech space.

ITGR : 74.10 (-1.48%)
SRDX : 63.84 (-1.69%)
VEEV : 91.38 (-2.27%)
MASI : 115.74 (-1.24%)
Global Neurovascular Devices Market to 2025 Featuring Stryker, Medtronic, MicroVention Terumo, Cerenovus, Penumbra, Microport Scientific & Integer Holdings

The "Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and Future Forecast (2018 - 2025)" report has been added to ResearchAndMarkets.com's...

ITGR : 74.10 (-1.48%)
Medtronic (MDT) Initiates ONYX ONE- Clear Study on DAPT

Following a DAPT interruption at one month on patients with a next generation DES, the Onyx ONE Clear Study by Medtronic (MDT) investigates risk of cardiac death, heart attack and stent thrombosis.

ITGR : 74.10 (-1.48%)
MASI : 115.74 (-1.24%)
MDT : 94.04 (-1.96%)
ISRG : 503.32 (-3.63%)
Integra Lifesciences Picked for Healogics iSupply Program

Integra Lifesciences' (IART) selection as a key provider for cellular-based tissue products within Healogics' new iSupply program to boost the top line.

ITGR : 74.10 (-1.48%)
IART : 62.38 (-1.72%)
MASI : 115.74 (-1.24%)
ISRG : 503.32 (-3.63%)
IDEXX Gains Ground on Solid CAG Business Amid Forex Woes

IDEXX (IDXX) continues to see strong organic growth, driven by solid sales at the CAG business. However, unfavorable currency movement remains a concern.

ITGR : 74.10 (-1.48%)
MASI : 115.74 (-1.24%)
IDXX : 218.94 (-2.40%)
ISRG : 503.32 (-3.63%)
Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake

Abbott (ABT) to see a rise in customer adoption of its DRG therapy following the receipt of new national coverage from Aetna.

AET : 201.04 (-0.22%)
ABT : 67.35 (-1.16%)
ITGR : 74.10 (-1.48%)
ISRG : 503.32 (-3.63%)
Here's Why You Should Hold On to Quest Diagnostics (DGX) Now

Tough competitive landscape and reimbursement issues are major deterrents to Quest Diagnostics' (DGX) top line in the near term. The company's focus on promising areas to drive growth is a positive.

ITGR : 74.10 (-1.48%)
DGX : 103.27 (+0.87%)
MASI : 115.74 (-1.24%)
ISRG : 503.32 (-3.63%)
Boston Scientific to Boost MedSurg Unit Via Augmenix Buyout

Boston Scientific (BSX) continues to adopt organic as well as inorganic means to boost top line.

ITGR : 74.10 (-1.48%)
BSX : 36.64 (-2.37%)
MASI : 115.74 (-1.24%)
ISRG : 503.32 (-3.63%)
Penumbra Launches Reperfusion Catheters, Boosts Neuro Unit

Penumbra (PEN) adopts initiatives to boost the highest revenue generating Neuro business.

ITGR : 74.10 (-1.48%)
PEN : 136.26 (-3.25%)
MASI : 115.74 (-1.24%)
ISRG : 503.32 (-3.63%)
Genomic Health Prostate Cancer Business Solid, Cost Woes Stay

Within the prostate cancer space, Genomic Health (GHDX) is seeing increasing private coverage for the Oncotype DX GPS test. Costs and operating expenses continue to rise.

ITGR : 74.10 (-1.48%)
GHDX : 65.94 (-2.97%)
MASI : 115.74 (-1.24%)
ISRG : 503.32 (-3.63%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More Share

Trade ITGR with:

Business Summary

Integer Holdings Corporation is a medical device outsource manufacturer. The company serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets. It also develops batteries for high-end niche applications in energy, military, and environmental markets. The...

See More

Key Turning Points

2nd Resistance Point 78.44
1st Resistance Point 76.82
Last Price 74.10
1st Support Level 74.17
2nd Support Level 73.13

See More

52-Week High 84.20
Last Price 74.10
Fibonacci 61.8% 68.27
Fibonacci 50% 63.35
Fibonacci 38.2% 58.43
52-Week Low 42.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar